Sibylle C Mellinghoff1,2, O A Cornely3,4,5,6, N Jung4. 1. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. Sibylle.mellinghoff@uk-koeln.de. 2. Department I for Internal Medicine, ECMM Excellence Centre of Medical Mycology, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. Sibylle.mellinghoff@uk-koeln.de. 3. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. 4. Department I for Internal Medicine, ECMM Excellence Centre of Medical Mycology, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. 5. German Centre for Infection Research, Partner-Site Bonn-Cologne (DZIF), Cologne, Germany. 6. Clinical Trials Centre Cologne (ZKS Köln), University Hospital Cologne, Cologne, Germany.
Abstract
AIMS: Due to the increase of severely immunocompromised patients, of invasive procedures including central intravascular catheters, and of the use of broad-spectrum antibiotics, the incidence of Candida bloodstream infections has risen intensely in the last decades. Candida bloodstream infection is a serious disease with high mortality. Optimized diagnostic and therapeutic management can improve outcome. Thus, the aim of our mini-review is to highlight important and often missed opportunities in the management of Candida bloodstream infection. METHODS: We searched the published literature and describe the essentials in the management of Candida bloodstream infection. RESULTS: Four essentials were identified: (1) isolation of Candida spp. from a blood culture should always be considered relevant and requires treatment. Daily blood cultures should be drawn to determine cessation of candidemia. (2) Central venous catheter (CVC) and/or other indwelling devices should be removed. (3) Echinocandins are the first choice. Antifungal treatment should be continued for at least 14 days after cessation of fungemia. Susceptibility testing should be performed to identify resistance and to facilitate transition to oral treatment. (4) In persistent candidemia, echocardiography is an important investigation; ophthalmoscopy should be considered. CONCLUSION: Further efforts should be undertaken to increase the adherence to the essentials in the management of Candia bloodstream infection.
AIMS: Due to the increase of severely immunocompromised patients, of invasive procedures including central intravascular catheters, and of the use of broad-spectrum antibiotics, the incidence of Candida bloodstream infections has risen intensely in the last decades. Candida bloodstream infection is a serious disease with high mortality. Optimized diagnostic and therapeutic management can improve outcome. Thus, the aim of our mini-review is to highlight important and often missed opportunities in the management of Candida bloodstream infection. METHODS: We searched the published literature and describe the essentials in the management of Candida bloodstream infection. RESULTS: Four essentials were identified: (1) isolation of Candida spp. from a blood culture should always be considered relevant and requires treatment. Daily blood cultures should be drawn to determine cessation of candidemia. (2) Central venous catheter (CVC) and/or other indwelling devices should be removed. (3) Echinocandins are the first choice. Antifungal treatment should be continued for at least 14 days after cessation of fungemia. Susceptibility testing should be performed to identify resistance and to facilitate transition to oral treatment. (4) In persistent candidemia, echocardiography is an important investigation; ophthalmoscopy should be considered. CONCLUSION: Further efforts should be undertaken to increase the adherence to the essentials in the management of Candia bloodstream infection.
Authors: O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann Journal: Clin Microbiol Infect Date: 2012-12 Impact factor: 8.067
Authors: Shellee A Grim; Karen Berger; Christine Teng; Sandeep Gupta; Jennifer E Layden; William M Janda; Nina M Clark Journal: J Antimicrob Chemother Date: 2011-12-18 Impact factor: 5.790
Authors: Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; Thomas J Walsh Journal: N Engl J Med Date: 2007-06-14 Impact factor: 91.245
Authors: Sophie Philips; Frederik Van Hoecke; Emmanuel De Laere; Steven Vervaeke; Roos De Smedt; Jerina Boelens; Deborah De Geyter; Denis Piérard; Katrien Lagrou Journal: J Fungi (Basel) Date: 2021-05-01
Authors: Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška Journal: J Fungi (Basel) Date: 2022-03-17